Frontlight ResearchEarly access
Trial site
Hospital Queen Elizabeth II
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Chronic kidney disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Primary biliary cholangitis1 trial
- Phase
- Phase 32 trials
- Phase 41 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Biosensors Europe SA1 trial
- Fondazione Ricerca e Innovazione Cardiovascolare ETS1 trial
- Ipsen1 trial
- Regeneron Pharmaceuticals1 trial
- University of Sydney1 trial
Running trials
Recruiting
Recruiting
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Active, not recruiting
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
Recruiting
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Primary biliary cholangitis1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026